MiR-96-5p influences cellular growth and is associated with poor survival in colorectal cancer patients.
Ress, AL; Stiegelbauer, V; Winter, E; Schwarzenbacher, D; Kiesslich, T; Lax, S; Jahn, S; Deutsch, A; Bauernhofer, T; Ling, H; Samonigg, H; Gerger, A; Hoefler, G; Pichler, M;
Mol Carcinog. 2015; 54(11): 1442-1450.
Full papers/articles (Journal)

Predicting the "usefulness" of 5-ALA-derived tumor fluorescence for fluorescence-guided resections in pediatric brain tumors: a European survey.
Stummer, W; Rodrigues, F; Schucht, P; Preuss, M; Wiewrodt, D; Nestler, U; Stein, M; Artero, JM; Platania, N; Skjøth-Rasmussen, J; Puppa, AD; Caird, J; Cortnum, S; Eljamel, S; Ewald, C; González-García, L; Martin, AJ; Melada, A; Peraud, A; Brentrup, A; Santarius, T; Steiner, HH;
Acta Neurochir (Wien). 2014; 156(12): 2315-2324.
Full papers/articles (Journal)

Induction of murine ras oncogene peptide-specific T cell responses by immunization with plasmid DNA-based minigene vectors.
Lindinger, P; Mostböck, S; Hammerl, P; Hartl, A; Thalhamer, J; Abrams, SI;
Vaccine. 2003; 21(27-30):4285-4296
Full papers/articles (Journal)

Simvastatin inhibits malignant transformation following expression of the Ha-ras oncogene in NIH 3T3 fibroblasts.
Fürst, J; Haller, T; Chwatal, S; Wöll, E; Dartsch, PC; Gschwentner, M; Dienstl, A; Zwierzina, H; Lang, F; Paulmichl, M; Ritter, M;
Cell Physiol Biochem. 2002; 12(1): 19-30.
Full papers/articles (Journal)

Effects of bradykinin on NIH 3T3 fibroblasts pretreated with lithium. Mimicking events of Ha-ras oncogene expression.
Ritter, M; Dartsch, P; Waldegger, S; Haller, T; Zwierzina, H; Lang, HJ; Lang, F;
Biochim Biophys Acta. 1997; 1358(1): 23-30.
Full papers/articles (Journal)

Activation of Na+/H(+)-exchanger by transforming Ha-ras requires stimulated cellular calcium influx and is associated with rearrangement of the actin cytoskeleton.
Ritter, M; Wöll, E; Haller, T; Dartsch, PC; Zwierzina, H; Lang, F;
Eur J Cell Biol. 1997; 72(3): 222-228.
Full papers/articles (Journal)

Modification of cellular ion transport by the Ha-ras oncogene: Steps towards malignant transformation
Ritter, M; Woll, E
CELL PHYSIOL BIOCHEM. 1996; 6(5): 245-270.
Reviews

Effects of calcium channel blockers on NIH 3T3 fibroblasts expressing the Ha-ras oncogene.
Dartsch, PC; Ritter, M; Gschwentner, M; Lang, HJ; Lang, F;
Eur J Cell Biol. 1995; 67(4): 372-378.
Full papers/articles (Journal)

Cytoskeletal reorganization in NIH 3T3 fibroblasts expressing the ras oncogene.
Dartsch, PC; Ritter, M; Häussinger, D; Lang, F;
Eur J Cell Biol. 1994; 63(2): 316-325.
Full papers/articles (Journal)

The biological significance of cell volume.
Lang, F; Ritter, M; Völkl, H; Häussinger, D;
Ren Physiol Biochem. 1993; 16(1-2): 48-65.
Reviews

Cell shrinkage stimulates bradykinin-induced cell membrane potential oscillations in NIH 3T3 fibroblasts expressing the ras-oncogene.
Ritter, M; Wöll, E; Waldegger, S; Häussinger, D; Lang, HJ; Scholz, W; Schölkens, B; Lang, F;
Pflugers Arch. 1993; 423(3-4): 221-224.
Full papers/articles (Journal)

FURTHER-STUDIES ON THE NATURE OF CELL-MEMBRANE POTENTIAL OSCILLATIONS IN NIH 3T3 FIBROBLASTS EXPRESSING THE RAS ONCOGENE
WALDEGGER, S; PINGGERA, G; KLOIBER, K; RITTER, M; WOLL, E; HUMPELER, E; MALY, K; GRUNICKE, H; LANG, F
CELL PHYSIOL BIOCHEM. 1993; 3(1): 89-96.
Full papers/articles (Journal)

Effects of HOE 694--a novel inhibitor of Na+/H+ exchange--on NIH 3T3 fibroblasts expressing the RAS oncogene.
Wöll, E; Ritter, M; Offner, F; Lang, HJ; Schölkens, B; Hüssinger, D; Lang, F;
Eur J Pharmacol. 1993; 246(3): 269-273.
Full papers/articles (Journal)

The role of calcium in cell shrinkage and intracellular alkalinization by bradykinin in Ha-ras oncogene expressing cells.
Wöll, E; Ritter, M; Scholz, W; Häussinger, D; Lang, F;
FEBS Lett. 1993; 322(3): 261-265.
Full papers/articles (Journal)

Altered cell volume regulation in ras oncogene expressing NIH fibroblasts.
Lang, F; Ritter, M; Wöll, E; Weiss, H; Häussinger, D; Hoflacher, J; Maly, K; Grunicke, H;
Pflugers Arch. 1992; 420(5-6): 424-427.
Full papers/articles (Journal)

Effects of inhibitors and ion substitutions on oscillations of cell membrane potential in cells expressing the RAS oncogene.
Lang, F; Waldegger, S; Woell, E; Ritter, M; Maly, K; Grunicke, H;
Pflugers Arch. 1992; 421(5): 416-424.
Full papers/articles (Journal)

Cell membrane potential oscillations induced by kinins in fibroblasts expressing the Ha-ras oncogene.
Lang, F; Wöll, E; Waldegger, S; Friedrich, F; Ritter, M; Pinggera, G; Kloiber, K; Bichler, I; Heitzenberger, H; Maly, K;
Agents Actions Suppl. 1992; 38 ( Pt 2): 73-80.
Full papers/articles (Journal)

Effects of bradykinin on cell volume and intracellular pH in NIH 3T3 fibroblasts expressing the ras oncogene.
Ritter, M; Wöll, E; Häussinger, D; Lang, F;
FEBS Lett. 1992; 307(3): 36-70.
Full papers/articles (Journal)